Sleep disorder
Conditions
Interventions
Trial Group:0.4% Lidocaine, 4mL, ultrasound-guided stellate ganglion block (SGB) treatment, total 7 times
Control Group:1% Lidocaine, 4mL, ultrasound-guided stellate ganglion block (SGB) treatment, total 7 times
Sponsors
Zhejiang Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age 18–65 years, both sexes included; 2. The patient requires ultrasound-guided stellate ganglion block (SGB) therapy for insomnia; 3. PSQI total score > 7; ISI total score > 7; 4. Agrees to participate in the study and signs informed consent;
Exclusion criteria
Exclusion criteria: 1. Puncture site infection; severe coagulation dysfunction; history of neck surgery; 2. Allergy to lidocaine; 3. Severe systemic diseases, such as cardiovascular, cerebrovascular, respiratory, hepatic, or renal diseases; 4. Participants currently enrolled in another clinical trial; 5. Communication difficulties; 6. Other reasons, as deemed unsuitable for clinical trial by the researchers;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Horner's syndrome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Insomnia Severity Index (ISI) score;Pittsburgh Sleep Quality Index (PSQI) score;Hamilton Anxiety Rating Scale (HARS) score;Hamilton Depression Rating Scale (HDRS) score;Electromyography (skin sympathetic activity and heart rate variability); | — |
Countries
China
Contacts
Public ContactWu Xiaomin
Zhejiang Provincial People's Hospital
Outcome results
None listed